CJChristopher Jantzen

Christopher Jantzen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher Jantzen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Lars Bo Ebskov

    Foot and Ankle Surgeon, Chief Physician, Department of Orthopedic Surgery, Foot and Ankle Division, Hvidovre University Hospital, Copenhagen, Denmark

    4 shared publications
  • Henrik Loevendahl Jørgensen

    Department of Clinical Biochemistry, Copenhagen University Hospital, Hvidovre, Denmark

    3 shared publications
  • Jens Kurt Johansen

    Chief Physician and Foot and Ankle Surgeon, Department of Orthopedic Surgery, Foot and Ankle Division, Hvidovre University Hospital, Copenhagen, Denmark

    3 shared publications
  • Jes Bruun Lauritzen

    Department of Orthopedic Surgery, Bispebjerg Hospital, Copenhagen, Denmark

    3 shared publications
  • Kim Hegnet Andersen

    Chief Physician and Foot and Ankle Surgeon, Department of Orthopedic Surgery, Foot and Ankle Division, Hvidovre University Hospital, Copenhagen, Denmark

    3 shared publications
  • Mostafa Benyahia

    Chief Physician and Foot and Ankle Surgeon, Department of Orthopedic Surgery, Foot and Ankle Division, Hvidovre University Hospital, Copenhagen, Denmark

    3 shared publications

Latest Publications

  • Overnight Admission After Total Ankle Replacement: Is It Safe?

    by Christopher Jantzen, Lars Bo Ebskov, Kim Hegnet Andersen, Mostafa Benyahia, Peter Bro Rasmussen, Jens Kurt Johansen


    • 12 October 2020
      • Vol. 182  (42)

    [Ankle arthrosis].

    by Christopher Jantzen, Lars Bo Ebskov, Kim Hegnet Andersen, Mostafa Benyahia, Peter Bro Rasmussen, Jens Kurt Johansen

    Symptomatic ankle arthrosis affects 1-4% of the population, and the most common aetiology is post-traumatic. Symptoms include pain, swelling and reduced range of motion. Diagnosis is based on weight-bearing X-rays of the ankle joint, and treatment depends on the arthrosis grade and patient characteristics. Non-operative therapy, i.e. physiotherapy, analgesics, injection therapy and/or braces/orthoses is first-line treatment, as we argue in this review. Arthroscopy can be an effective treatment for some patients, but in case of severe arthrosis, osteotomies, total ankle replacement or arthrodesis may be necessary.


  • The Effect of a Single Hyaluronic Acid Injection in Ankle Arthritis: A Prospective Cohort Study

    by Christopher Jantzen, Lars Bo Ebskov, Kim Hegnet Andersen, Mostafa Benyahia, Peter Bro Rasmussen, Jens Kurt Johansen


  • Open Access

    Temporal trends in hip fracture incidence, mortality, and morbidity in Denmark from 1999 to 2012

    by Christopher Jantzen, Christian M Madsen, Jes B Lauritzen, Henrik L Jørgensen

    Background and purpose — While development in hip fracture incidence and mortality is well examined, none has yet looked at the temporal trends regarding prevalence of co-morbidities. Therefore we investigated changes in incidence of first hip fracture, co-morbidity prevalence, 30 day- and 1-year mortality in hip fracture patients in the Danish population during the period 1999 to 2012. Patients and methods — Patients >18 years admitted with a fractured hip in Denmark between 1996 and 2012 were identified with data for the period 1999–2012 being analyzed regarding prevalence of co-morbidities, incidence, and mortality. Results — 122,923 patients were identified. Incidence in the whole population declined but sex-specific analysis showed no changes for men. For the whole study population, 30-day and 1-year mortality remained unchanged. Age at time of first hip fracture also remained unchanged. Of the included co-morbidities a decrease in prevalence of malignancy and dementia in women was found while there was an increase in the prevalence of all remaining co-morbidities, except hemi- or paraplegia for both sexes, rheumatic diseases for women, and for men diabetes with complications, myocardial infarction, AIDS/HIV, and malignancy. Interpretation — While hip fracture incidence declined for women it was unchanged for men; likewise, 30-day and 1-year mortality rates together with age at first fracture remained unchanged. When these results are compared with the relatively large increase in the prevalence of co-morbidities, it does not seem likely that the increased disease burden is affecting either the incidence or the mortality.


  • Colles’ fractures and osteoporosis—A new role for the Emergency Department

    by Christopher Jantzen, Lars K. Cieslak, Ayob F. Barzanji, Per B. Johansen, Søren W. Rasmussen, Thomas A. Schmidt


    • 1 March 2014
      • Vol. 61  (3) , A4794

    Daily number of fractures is associated with road temperature in an urban area.

    by Christopher Jantzen, Henrik Løvendahl Jørgensen, Morten T Thomsen, Troels Riis, Bo Sommer, Benn R Duus, Jes Bruun Lauritzen

    Different factors related to winter are known to influence the fracture incidence, but little is known about the effect of road surface temperature. This study examines the association between road surface temperature and the daily number of fractures in an urban area during two winters. Retrospective data collection was conducted on all patients treated at Bispebjerg Hospital, Denmark, for a humeral, ankle, distal radius or hip fracture during the periods October to April 2009/2010 and 2010/2011. Patients were grouped according to age into the following categories: < 15, 15-30, 30-45, 45-60 and > 60 years. Data on road surface temperature (Tp.) were obtained from The Danish Road Directorate and grouped into the following categories: Days with Tp. > 0 °C, Tp. < 0 °C, Tp. > -5 °C, Tp. < -5 °C and ice alert (IA). A total of 4,892 patients (4,938 fractures) were treated during the study periods. The daily number of distal radius, humeral and ankle fractures increased significantly with decreasing road surface temperature and the presence of IA. For hip fractures no significant association was found. Decreasing temperature was associated with a significant decrease in the daily number of fractures for patients < 15 years, whereas patients > 30 years experienced a significant increase. Decreasing road temperature results in increased numbers of all fractures except hip fractures. Low temperatures is a risk factor for patients > 30 years and a protective factor for patients < 15 years. not relevant. not relevant.


  • Open Access

    Chromium and cobalt ion concentrations in blood and serum following various types of metal-on-metal hip arthroplasties

    by Christopher Jantzen, Henrik L Jørgensen, Benn R Duus, Sune L Sporring, Jes B Lauritzen

    Widely different metal ion concentrations in blood and serum have been reported with metal-on-metal (MoM) implants. We reviewed the literature on blood and serum ion concentrations of chromium (Cr) and cobalt (Co) following various MoM hip arthroplasties. Studies were searched for in the Medline database, Embase, and the Cochrane Database of Systematic Reviews. Highest mean or median ion concentrations of Cr and Co after a minimum of 1 year of follow-up were extracted and grouped according to sample- and articulation type, and average values were calculated. 43 studies were included and 16 different MoM implants were identified. For the different types of bearings, average ion concentrations and range were calculated from the mean or median ion concentration. The average Cr concentration ranged between 0.5 and 2.5 μg/L in blood and between 0.8 and 5.1 μg/L in serum. For Co, the range was 0.7-3.4 μg/L in blood and 0.3-7.5 μg/L in serum. When the average blood ion concentrations calculated for the different implants, together with the concentrations measured in the individual studies, were compared with the upper acceptable limit for Cr and Co in blood, no clear pattern was recognized. Furthermore, we were unable to detect any clear difference in ion concentrations between different types of implants (THA and resurfacing).